TaVNS closed-loop regulation and control method for high-inflammation ARDS
Through dual-band aphrodisiac impedance analysis and lightweight inflammatory risk prediction model, the frequency and current intensity of taVNS are dynamically adjusted, solving the problem that the existing taVNS methods cannot adjust parameters according to the inflammatory state, and achieving efficient and safe treatment effects.
Patent Information
- Application Number
- CN202510982948.X
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2025-07-16
- Publication Date
- 2025-09-05
AI Technical Summary
Existing percutaneous vagus nerve stimulation (taVNS) methods cannot dynamically adjust stimulation parameters according to the patient's inflammatory status, resulting in poor treatment effects and may cause side effects.
Dual-frequency aphrodisiac impedance analysis technology is used to measure low-frequency and high-frequency impedance parameters, calculate the neuron activation index, and conduct real-time evaluation through a lightweight inflammatory risk prediction model, and dynamically adjust the frequency and current intensity with multiple decision-making methods to form closed-loop regulation.
Accurate regulation based on the inflammatory state is achieved, side effects are reduced, and treatment effect and patient comfort are improved.